Hangzhou Tigermed Consulting Co (FRA:5HZ1) Margin of Safety % (DCF Dividends Based) : 34.91% (As of May. 16, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Hangzhou Tigermed Consulting Co Margin of Safety % (DCF Dividends Based)?

Margin of Safety % (DCF Dividends Based) = (Intrinsic Value: DCF (Dividends Based) - Current Price) / Intrinsic Value: DCF (Dividends Based).

Note: Discounted Dividend model is only suitable for companies who have a consistant distribution history with more than 5 years. If the company's dividends does not remain steady over a long period, results may not be accurate due to the low consistency. The model is also only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, the data will not be stored into our database.

As of today (2024-05-16), Hangzhou Tigermed Consulting Co's Predictability Rank is 4.5-Stars. Hangzhou Tigermed Consulting Co's intrinsic value calculated from the Discounted Dividend model is €7.06 and current share price is €4.14. Consequently,

Hangzhou Tigermed Consulting Co's Margin of Safety % (DCF Dividends Based) using Discounted Dividend model is 34.91%.

Competitive Comparison of Hangzhou Tigermed Consulting Co's Margin of Safety % (DCF Dividends Based)

For the Diagnostics & Research subindustry, Hangzhou Tigermed Consulting Co's Margin of Safety % (DCF Dividends Based), along with its competitors' market caps and Margin of Safety % (DCF Dividends Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hangzhou Tigermed Consulting Co's Margin of Safety % (DCF Dividends Based) Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Hangzhou Tigermed Consulting Co's Margin of Safety % (DCF Dividends Based) distribution charts can be found below:

* The bar in red indicates where Hangzhou Tigermed Consulting Co's Margin of Safety % (DCF Dividends Based) falls into.

Hangzhou Tigermed Consulting Co Margin of Safety % (DCF Dividends Based) Calculation

Hangzhou Tigermed Consulting Co's Margin of Safety % (DCF Dividends Based) for today is calculated as

Margin of Safety % (DCF Dividends Based)	=	(Intrinsic Value: DCF (Dividends Based)	-	Current Price)	/	Intrinsic Value: DCF (Dividends Based)
	=	(6.36	-	4.14)	/	6.36
	=	34.91 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The intrinsic value is calculated from the Discounted Dividend model with default parameters.

Hangzhou Tigermed Consulting Co Margin of Safety % (DCF Dividends Based) Related Terms

Thank you for viewing the detailed overview of Hangzhou Tigermed Consulting Co's Margin of Safety % (DCF Dividends Based) provided by GuruFocus.com. Please click on the following links to see related term pages.

Hangzhou Tigermed Consulting Co (FRA:5HZ1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Hangzhou Tigermed Consulting Co Ltd (FRA:5HZ1) » Definitions » Margin of Safety % (DCF Dividends Based)

Comparable Companies

Traded in Other Exchanges

HNGZY:USA 03347:Hong Kong 300347:China

Address

Block 8, No. 19 Jugong Road, Room 2001-2010, 20th Floor, Xixing Sub-District, Binjiang District, Hangzhou, CHN, 310053

Website

https://www.tigermed.net

Hangzhou Tigermed Consulting Co Ltd is a China-based Contract Research Organization. The company's segment includes Clinical trial solutions and Clinical-related and laboratory services. It generates maximum revenue from the Clinical trial solutions segment. The company's offered services include bioanalytical, medical writing, biostatistics analysis, and medical imaging. The therapeutic areas of the company include Infections, Hematology, Cardiovascular, Endocrinology, Rheumatology, Nephrology, and Central Nervous System (CNS) among others.

Hangzhou Tigermed Consulting Co (FRA:5HZ1) Headlines

No Headlines